MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
1.080
-0.080
-6.90%
After Hours: 1.081 +0.001 +0.09% 19:49 02/10 EST
OPEN
1.160
PREV CLOSE
1.160
HIGH
1.160
LOW
1.070
VOLUME
224.37K
TURNOVER
--
52 WEEK HIGH
10.40
52 WEEK LOW
0.6733
MARKET CAP
19.30M
P/E (TTM)
-0.1433
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XAIR last week (0202-0206)?
Weekly Report · 1d ago
Analysts’ Top Healthcare Picks: Beyond Air (XAIR), Molina Healthcare (MOH)
TipRanks · 5d ago
Beyond Air-Tochter Beyond Cancer präsentiert Phase-1-Daten zu UNO-Therapie auf AACR 2026
Reuters · 6d ago
Beyond Cancer Showcases Phase 1 UNO Data at AACR 2026
Reuters · 6d ago
Beyond Air Stockholders Approve Directors and Equity Plan
TipRanks · 02/02 21:39
Weekly Report: what happened at XAIR last week (0126-0130)?
Weekly Report · 02/02 10:16
Beyond Air files to sell 7.86M shares of common stock for holders
TipRanks · 01/30 21:10
XTL Biopharmaceuticals provides update on recent developments
TipRanks · 01/29 21:40
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.